Yüklüyor......
Hyperbilirubinemia in atazanavir treated HIV-infected patients: the impact of the UGT1A1*28 allele
Combination antiretroviral treatment (cART) has significantly improved the life expectancy of people living with HIV. The life-long nature of cART increases the risk of side effects, which in some cases may have been caused by specific genetic characteristics. Patients treated with atazanavir (ATV)...
Kaydedildi:
| Yayımlandı: | Pharmgenomics Pers Med |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove Medical Press
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5488765/ https://ncbi.nlm.nih.gov/pubmed/28790862 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PGPM.S107152 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|